BACKGROUND:Ethanol has a broad range of actions on many neurotransmitter systems. The depressant actions of ethanol in the brain are related in part to facilitation of gamma-aminobutyric acid (GABA) neurotransmission via its interaction with the benzodiazepine/GABA receptor complex. The purpose of this study was to evaluate the effects of ethanol on regional brain metabolism in 10 healthy right-handed men. The results were compared with those we previously published in a different group of 16 normal male subjects who receivedintravenous lorazepam, a benzodiazepine drug that also enhances GABA neurotransmission. METHODS: The subjects were scanned with positron emission tomography and [F-18] fluorodeoxyglucose twice: 40 min after the end of placebo (diet soda) or ethanol (0.75 g/kg) oral administration. Image data sets were analyzed by using both the region of interest and the statistical parametric mapping (SPM) approach. SPM was used to generate a difference image between baseline and ethanol, which we compared to the difference image between baseline and lorazepam (30 microg/kg). RESULTS:Ethanol significantly increased self-reports of "high" (p < or = 0.0001), dizziness (p < or = 0.004), and intoxication (p < or = 0.0001). Ethanol significantly decreased whole brain (-25 +/- 6%, p < or = 0.0001) and regional metabolism. Normalization of the regional measures by whole brain metabolism (relative measures) showed that ethanol decreased relative metabolic activity in occipital cortex (-4.9 +/- 4.1%, p < or = 0.006), whereas it increased relative metabolic act in left temporal cortex (+3.5 +/- 2.9%, p < or = 0.006) and left basal ganglia (+9 +/- 6.3%, p < or = 0.0009). SPM analyses revealed the same pattern of responses as the relative measures, showing decreases in occipital cortex and increases in left temporal cortex. Comparison of the relative measures and the SPM analyses obtained with lorazepam data revealed a similar pattern of effects, with relative decreases in occipital cortex (-7.8 +/- 4.8%) and relative increases in left temporal cortex (+3.8 +/- 5.7%). Lorazepam, but not ethanol, also decreased thalamic metabolism (-11.2 +/- 7.2%). CONCLUSIONS: These results support similar though not identical mechanisms for the effects of alcohol and benzodiazepines on brain glucose metabolism. The fact that lorazepam, but not alcohol, reduced thalamic metabolism, an effect associated with sleepiness, could explain the higher sedative effects of lorazepam than of alcohol.
RCT Entities:
BACKGROUND:Ethanol has a broad range of actions on many neurotransmitter systems. The depressant actions of ethanol in the brain are related in part to facilitation of gamma-aminobutyric acid (GABA) neurotransmission via its interaction with the benzodiazepine/GABA receptor complex. The purpose of this study was to evaluate the effects of ethanol on regional brain metabolism in 10 healthy right-handed men. The results were compared with those we previously published in a different group of 16 normal male subjects who received intravenous lorazepam, a benzodiazepine drug that also enhances GABA neurotransmission. METHODS: The subjects were scanned with positron emission tomography and [F-18] fluorodeoxyglucose twice: 40 min after the end of placebo (diet soda) or ethanol (0.75 g/kg) oral administration. Image data sets were analyzed by using both the region of interest and the statistical parametric mapping (SPM) approach. SPM was used to generate a difference image between baseline and ethanol, which we compared to the difference image between baseline and lorazepam (30 microg/kg). RESULTS:Ethanol significantly increased self-reports of "high" (p < or = 0.0001), dizziness (p < or = 0.004), and intoxication (p < or = 0.0001). Ethanol significantly decreased whole brain (-25 +/- 6%, p < or = 0.0001) and regional metabolism. Normalization of the regional measures by whole brain metabolism (relative measures) showed that ethanol decreased relative metabolic activity in occipital cortex (-4.9 +/- 4.1%, p < or = 0.006), whereas it increased relative metabolic act in left temporal cortex (+3.5 +/- 2.9%, p < or = 0.006) and left basal ganglia (+9 +/- 6.3%, p < or = 0.0009). SPM analyses revealed the same pattern of responses as the relative measures, showing decreases in occipital cortex and increases in left temporal cortex. Comparison of the relative measures and the SPM analyses obtained with lorazepam data revealed a similar pattern of effects, with relative decreases in occipital cortex (-7.8 +/- 4.8%) and relative increases in left temporal cortex (+3.8 +/- 5.7%). Lorazepam, but not ethanol, also decreased thalamic metabolism (-11.2 +/- 7.2%). CONCLUSIONS: These results support similar though not identical mechanisms for the effects of alcohol and benzodiazepines on brain glucose metabolism. The fact that lorazepam, but not alcohol, reduced thalamic metabolism, an effect associated with sleepiness, could explain the higher sedative effects of lorazepam than of alcohol.
Authors: Peter Kochunov; Carlos Castro; Duff M Davis; Donald Dudley; Hsiao-Ying Wey; David Purdy; Peter T Fox; Calvin Simerly; Gerald Schatten Journal: Neuroreport Date: 2010-07-14 Impact factor: 1.837
Authors: Nora D Volkow; Yeming Ma; Wei Zhu; Joanna S Fowler; Juan Li; Manlong Rao; Klaus Mueller; Kith Pradhan; Christopher Wong; Gene-Jack Wang Journal: Psychiatry Res Date: 2008-02-15 Impact factor: 3.222
Authors: Ryan S Trim; Alan N Simmons; Neil J Tolentino; Shana A Hall; Scott C Matthews; Shannon K Robinson; Tom L Smith; Claudia B Padula; Martin P Paulus; Susan F Tapert; Marc A Schuckit Journal: Alcohol Clin Exp Res Date: 2010-05-07 Impact factor: 3.455
Authors: Dardo G Tomasi; Corinde E Wiers; Ehsan Shokri-Kojori; Amna Zehra; Veronica Ramirez; Clara Freeman; Jamie Burns; Christopher Kure Liu; Peter Manza; Sung W Kim; Gene-Jack Wang; Nora D Volkow Journal: Int J Neuropsychopharmacol Date: 2019-09-01 Impact factor: 5.176
Authors: Najmeh Khalili-Mahani; Remco M W Zoethout; Christian F Beckmann; Evelinda Baerends; Marieke L de Kam; Roelof P Soeter; Albert Dahan; Mark A van Buchem; Joop M A van Gerven; Serge A R B Rombouts Journal: Hum Brain Mapp Date: 2011-03-09 Impact factor: 5.038
Authors: Najmeh Khalili-Mahani; Matthias J van Osch; Mark de Rooij; Christian F Beckmann; Mark A van Buchem; Albert Dahan; Johannes M van Gerven; Serge A R B Rombouts Journal: Hum Brain Mapp Date: 2012-12-26 Impact factor: 5.038